Mounjaro
Mounjaro is a brand name for the medication tirzepatide, developed by Eli Lilly. It is an injectable medication used for the treatment of type 2 diabetes and has gained attention for its effectiveness in lowering blood sugar levels and promoting weight loss, making it a popular choice among patients.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Mounjaro is a popular injectable drug that Eli Lilly's Orforglipron is compared to.
7